A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants

NCT02993926 · clinicaltrials.gov ↗

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Precocious Puberty

Interventions

DRUG: Enantone
DRUG: GnRH agonist

Sponsor

Takeda